AZA Treatment Induced Dose-Dependent 5hmC Changes which were Prognostic AZA treatment is known to affect the genome-wide distribution of DNA 5mC and 5hmC modifications, which have been widely used for the diagnosis and prognosis of various types of cancer.[13] To understand the epigenetic modulation effect of AZA treatment, we characterized genome-wide 5hmC profiles for 120 BM and/or PB samples obtained from 40 patients at Day 0 and/or Day 5 through Nano-hmC-Seal.[26] There were only 19...